Preventive administration of thiazolidinediones did in fact provide beneficial effects in murine models of ulcerative colitis but was less efficient when administered after the onset of the disease because PPARγ was shown to be downregulated by colitis-induced inflammatory processes [30]. This evidence concerns the gene PPARG and colitis.